Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ArriVent BioPharma, Inc. | Chief Operating Officer | Common Stock | 394K | $1.44M | $3.65 | Sep 19, 2024 | Held by The MAKS Yao Trust |
ArriVent BioPharma, Inc. | Chief Operating Officer | Common Stock | 125K | $455K | $3.65 | Sep 19, 2024 | Direct |
ArriVent BioPharma, Inc. | Chief Operating Officer | Stock Option (right to buy) | 56.5K | Sep 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVBP | ArriVent BioPharma, Inc. | Sep 19, 2024 | 10 | $90.5K | 4 | Sep 23, 2024 | Chief Operating Officer |
AVBP | ArriVent Biopharma, Inc. | Jan 25, 2024 | 0 | $0 | 3 | Jan 25, 2024 | Chief Operating Officer |